The Life Sciences Industrial Strategy made clear that if patients are to access cutting edge and innovative new treatments then industry and the NHS need to collaborate more effectively. HSJ and Wilmington Healthcare have launched the Life Sciences Forum to bring together senior leaders from the NHS, top executives from industry and the core stakeholders from Government, NHS England and regulatory bodies.
For industry the benefits of attending this event are clear:
- Develop stronger relationships with NHS leaders from NHS England, RMOCS, STPs and ICSs
- Influence debate around the direction of travel for medicines by taking a seat round the table with key stakeholders from Government and regulatory bodies
- Understand the challenges facing the NHS by learning about the priorities at a local and national level
- Find out about partnership working approaches through collaboration with AHSNs
The high-level speakers at the event include:
- Ian Dodge, National Director – Strategy and Innovation, NHS England
- Steve Oldfield, Chief Commercial Officer, Department of Health and Social Care
- Ellen Rule, Director of Transformation and Service Redesign, Gloucestershire STP
- Clare Morgan, Programme Director, South Yorkshire and Bassetlaw STP
- Bill Gillespie, Chief Executive, Wessex AHSN
- Dr Ian Hudson,Chief Executive, MHRA
- Dr Nigel Acheson, Regional Medical Director (South), NHS England
- Rowena Burns, Chief Executive, Manchester Science Partnerships
- Mike Thompson, Chief Executive, ABPI
- Meindert Boysen, Programme Director, Technology Appraisals,NICE
- Ben Bridgewater, Chief Executive, Health Innovation Manchester
View or download the programme at lifesciences.hsj.co.uk